Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oral Anti-Tick Vaccine (US Biologic)
- Development stage
- Preclinical
- Lead developer
- US Biologic
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
US Biologic is developing an oral anti-tick vaccine using its proprietary OrisBio platform, which utilizes *Bacillus subtilis* spores as a delivery vehicle for universal tick antigens. Developed in partnership with the USDA Agricultural Research Service, the vaccine is designed to induce an immune response in host animals against conserved tick proteins. When ticks feed on vaccinated animals, the ingested antibodies kill or impair the ticks, effectively reducing tick populations and interrupting the transmission cycle of various tick-borne diseases. The OrisBio platform employs heat-stable, non-GMO spores that survive the gastrointestinal environment and provide intrinsic molecular adjuvantization, allowing for needle-free administration to wildlife or livestock without the need for refrigeration.
- Other names
- OrisBio anti-tick vaccineUS Biologic oral anti-tick vaccine
Beyond the preview
Go deeper on Oral Anti-Tick Vaccine (US Biologic).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oral Anti-Tick Vaccine (US Biologic).